Danielle Antalffy

Stock Analyst at UBS

(3.46)
# 926
Out of 5,150 analysts
202
Total ratings
46.55%
Success rate
5.55%
Average return

Stocks Rated by Danielle Antalffy

RxSight
Feb 26, 2026
Maintains: Neutral
Price Target: $8$9
Current: $7.62
Upside: +18.11%
Stryker
Feb 24, 2026
Maintains: Neutral
Price Target: $386$400
Current: $384.59
Upside: +4.01%
Tandem Diabetes Care
Feb 20, 2026
Maintains: Neutral
Price Target: $17$22
Current: $23.74
Upside: -7.33%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $60$55
Current: $31.46
Upside: +74.83%
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $140$120
Current: $73.85
Upside: +62.49%
Zimmer Biomet Holdings
Jan 28, 2026
Maintains: Sell
Price Target: $88$86
Current: $97.97
Upside: -12.22%
Edwards Lifesciences
Jan 12, 2026
Maintains: Neutral
Price Target: $92$95
Current: $85.28
Upside: +11.40%
Sight Sciences
Dec 23, 2025
Maintains: Buy
Price Target: $7$12
Current: $5.26
Upside: +128.14%
Inspire Medical Systems
Dec 23, 2025
Maintains: Neutral
Price Target: $89$91
Current: $65.80
Upside: +38.30%
Glaukos
Dec 23, 2025
Maintains: Buy
Price Target: $140$145
Current: $117.75
Upside: +23.14%
Initiates: Buy
Price Target: $62
Current: $26.26
Upside: +136.10%
Maintains: Neutral
Price Target: $95$102
Current: $96.71
Upside: +5.47%
Upgrades: Buy
Price Target: $355$400
Current: $241.84
Upside: +65.40%
Maintains: Neutral
Price Target: $6.5$5.85
Current: $1.57
Upside: +272.61%
Maintains: Neutral
Price Target: $16$16
Current: $13.60
Upside: +17.65%
Maintains: Buy
Price Target: $106$95
Current: $73.08
Upside: +29.99%
Maintains: Neutral
Price Target: $24$21
Current: $19.03
Upside: +10.35%
Maintains: Neutral
Price Target: $585$600
Current: $497.42
Upside: +20.62%
Maintains: Buy
Price Target: $190$214
Current: $246.75
Upside: -13.27%
Maintains: Buy
Price Target: $65$57
Current: $25.29
Upside: +125.39%
Maintains: Buy
Price Target: $146$148
Current: $113.61
Upside: +30.27%
Initiates: Neutral
Price Target: $2.25
Current: $3.68
Upside: -38.86%
Maintains: Outperform
Price Target: $975$825
Current: $3.48
Upside: +23,606.90%
Maintains: Outperform
Price Target: $12$14
Current: $29.83
Upside: -53.07%
Maintains: Outperform
Price Target: $75$100
Current: $78.84
Upside: +26.84%
Maintains: Outperform
Price Target: $15$12
Current: $13.83
Upside: -13.23%
Maintains: Outperform
Price Target: $40$45
Current: $34.39
Upside: +30.85%
Maintains: Market Perform
Price Target: $270$275
Current: $174.21
Upside: +57.86%
Maintains: Outperform
Price Target: $26$20
Current: $2.87
Upside: +596.86%
Maintains: Market Perform
Price Target: $72$42
Current: $6.21
Upside: +576.33%
Downgrades: Market Perform
Price Target: $60
Current: $6.83
Upside: +779.12%
Initiates: Outperform
Price Target: $15
Current: $0.80
Upside: +1,775.00%